日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

US EUROPE AFRICA ASIA 中文
Business / Companies

Guilin at forefront in battle against malaria

By Wang Hongyi (China Daily) Updated: 2015-11-09 09:47

Since 2000, global mortality rates among malaria patients have dropped by 47 percent. In Africa, the rate has come down by 54 percent for adults and 58 percent for children.

GPSC has played an important role, along with major global pharmaceutical companies such as Novartis in Switzerland and Sanofi-Aventis in France, in fighting malaria.

The Chinese company was at the forefront in developing the innovative artesunate vaccine, Artsun, the first of its kind, to replace quinine injections. The WHO has compared it to the "gold standard" in the battle against malaria.

Artsun is now registered in more than 30 countries and regions and has a 90 percent market share in treating servere malaria.

During the past three years, GPSC has supplied 23.8 million units of the vaccine globally, saving more than 3.4 million people from the scourge of malaria.

"This is an innovative drug that was developed in China," Guo Guangchang, chairman of Fosun Group, said.

During the past decade, 13 anti-malaria drugs developed by GPSC have been approved by the WHO, including three which are injected and 10 in oral tablets.

The company's products account for 80 percent of China's anti-malaria drug exports.

In the first three quarters of this year, Fosun Pharmaceutical, which includes GPSC, reported revenue of 9 billion yuan ($1.41 billion), a rise of 4.76 percent compared to the same period in 2014.

Further financial details have yet to be released. The company's products include metabolism and digestive system drugs, and vaccines, as well as GPSC's brands.

"At present, Guilin Pharma is building a new manufacturing site which will comply with (international) standards," GPSC said.

"In future, we will have a production capacity of over 15 billion tablets/capsules per year to meet the needs of both domestic and global markets." the company added.

Fosun Pharmaceutical also plans to expand its research and development program by working alongside institutions and other organizations.

"There should be more cooperation with research institutes and organizations," Chen Qiyu, chairman of Fosun Pharmaceutical, said.

"This would help create a much larger platform, allowing us to do a better job globally."

Previous Page 1 2 Next Page

Hot Topics

Editor's Picks
...
主站蜘蛛池模板: 亚洲第一免费播放区 | 国产伦精品一区二区三区视频黑人 | 久久九九视频 | 黄色片成年人 | 999精品视频在线观看播放 | 日女人逼逼 | 久久激情片 | 日韩综合图区 | 99视频热| 日日弄天天弄美女bbbb | 色婷婷国产精品免 | 久久不色 | 一区二区三区日韩视频 | 99re免费视频 | 国产精品一区二区三区不卡 | 亚洲天堂午夜 | 久久色在线观看 | 色日韩| 久久免费高清视频 | 免费中文字幕日韩欧美 | 一本一道精品欧美中文字幕 | 四虎成人影视 | 成人免费av在线 | 1024黄色| 欧美a级在线观看 | 91精品久久久久久久 | 中文字幕自拍 | 亚洲男女视频 | 黄色网页在线免费观看 | 三级中文字幕 | 成人免费黄色 | 日韩视频一区二区三区 | 欧美激情一区二区三区 | 欧美天堂| 国产区精品在线 | 日韩乱码一区二区三区 | 免费av网址大全 | 91精品国产乱码久久久 | 香蕉av在线 | 天堂资源av | 夜夜久久久 |